Suppr超能文献

机器人辅助治疗寡转移肾肿瘤合并同步胰腺转移:病例报告及文献复习

Robotic treatment of oligometastatic kidney tumor with synchronous pancreatic metastasis: case report and review of the literature.

作者信息

Boni Andrea, Cochetti Giovanni, Ascani Stefano, Del Zingaro Michele, Quadrini Francesca, Paladini Alessio, Cocca Diego, Mearini Ettore

机构信息

Department of Surgical and Biomedical Sciences, Division of Urological, Andrological surgery and Minimally-invasive techniques, University of Perugia, Perugia, Italy.

Institute of Pathologic Anatomy, "Santa Maria" Hospital, Terni, Italy.

出版信息

BMC Surg. 2018 Jun 13;18(1):40. doi: 10.1186/s12893-018-0371-x.

Abstract

BACKGROUND

The management of metastatic Renal Cell Carcinoma (RCC) has changed dramatically in the last 20 years, and the role of surgery in the immunotherapy's era is under debate. Metastatic lesions interesting pancreas are infrequent, but those harbouring from RCC have an high incidence. If metachronous resections are not rare, synchronous resection of primary RCC and its pancreatic metastasis is uncommonly reported, and accounts for a bad prognosis.

CASE PRESENTATION

We report the case of a 68 years old woman, who presented hematuria at hospital incoming, with radiological appearance of a 13 cm left renal mass, with a 2.5 cm single pancreatic tail metastasis. Work-up of staging ruled out other distant metastases, urothelial cancer and there was no evidence of inferior vena cava thrombosis. We choose a 5-port trans-peritoneal robotic approach using lazy right lateral decubitus. Synchronous robotic radical nephrectomy and spleen-sparing pancreatic resection was performed. The pancreatic mass was completely enucleated from pancreatic parenchyma using a latero-medial dissection. Peri-operative hemoglobine loss was 2.4 g/dL. Total operative time was 213 min. No post-operative complications were recorded and patient was discharged in 7th post-operative day. Histopathological examination showed a pT2b N0 M1 RCC, Fuhrman grade II, with pancreatic tail metastasis; both, primary and metastatic lesions had the same histological characteristics with negative surgical margins. After 9 months patient had no evidence of disease recurrence at radiological studies.

CONCLUSIONS

The rationale for surgical removal of disseminated tumor, followed by immunotherapy, includes improving prognosis and enhancing the potential of an immune-mediated response to systemic treatment. A spleen-sparing procedure can adequately preserve post-operative immunologic capabilities. In our experience, the correct assessment of pre-operative imaging data and surgeon skills in robotic surgery seem to play a key role in the success of these procedures. Robotic surgery seems to enhance the possibility to control multiple vessels encountered during dissection. Such a conservative approach may be helpful in future research aimed at uncovering biological features, and also leading to better targeted preventive interventions and more individualized and effective treatments.

摘要

背景

在过去20年中,转移性肾细胞癌(RCC)的治疗发生了巨大变化,手术在免疫治疗时代的作用存在争议。累及胰腺的转移性病变并不常见,但源自RCC的病变发生率较高。异时性切除并不罕见,但原发性RCC及其胰腺转移灶的同步切除报道较少,且预后不良。

病例报告

我们报告了一例68岁女性,入院时出现血尿,影像学显示左肾有一个13 cm的肿块,伴有一个2.5 cm的胰腺尾部单发转移灶。分期检查排除了其他远处转移、尿路上皮癌,且没有下腔静脉血栓形成的证据。我们采用右侧卧位的5孔经腹机器人手术入路。进行了同步机器人根治性肾切除术和保留脾脏的胰腺切除术。通过外侧向内侧解剖从胰腺实质中完整摘除胰腺肿块。围手术期血红蛋白损失为2.4 g/dL。总手术时间为213分钟。未记录到术后并发症,患者在术后第7天出院。组织病理学检查显示为pT2b N0 M1肾透明细胞癌,Fuhrman分级II级,伴有胰腺尾部转移;原发性和转移性病变具有相同的组织学特征,手术切缘阴性。9个月后,影像学检查未发现疾病复发迹象。

结论

手术切除播散性肿瘤后进行免疫治疗的理论依据包括改善预后和增强全身治疗免疫介导反应的潜力。保留脾脏的手术可以充分保留术后免疫功能。根据我们的经验,术前影像学数据的正确评估和机器人手术中的外科医生技能似乎在这些手术的成功中起着关键作用。机器人手术似乎增加了控制解剖过程中遇到的多条血管的可能性。这种保守方法可能有助于未来旨在揭示生物学特征的研究,并有助于实现更好的靶向预防干预以及更个性化和有效的治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验